Zevra Therapeutics, Inc. (ZVRA)
(Delayed Data from NSDQ)
$6.99 USD
+0.21 (3.10%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $6.99 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.48 |
Last EPS Surprise | -2.13% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.57 |
Next Year | -0.21 |
EPS (TTM) | -1.68 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.38M | 14.81M | 27.70M | 105.47M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 5.56M | 24.33M | 37.91M | 130.87M |
Low Estimate | 5.07M | 9.90M | 21.97M | 86.63M |
Year ago Sales | 2.90M | 13.22M | 27.46M | 27.70M |
Year over Year Growth Est. | 85.38% | 12.00% | 0.86% | 280.81% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.22 | -1.57 | -0.21 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.49 | -0.48 | -1.65 | 0.26 |
High Estimate | -0.42 | -0.05 | -1.33 | 0.26 |
Low Estimate | -0.48 | -0.32 | -1.68 | -0.63 |
Year ago EPS | -0.40 | -0.40 | -1.30 | -1.57 |
Year over Year Growth Est. | -12.50% | 45.00% | -20.77% | 86.84% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.22 | -1.57 | -0.21 |
7 Days Ago | -0.45 | -0.22 | -1.57 | -0.21 |
30 Days Ago | -0.45 | -0.22 | -1.57 | -0.20 |
60 Days Ago | -0.44 | -0.20 | -1.55 | -0.13 |
90 Days Ago | -0.43 | -0.20 | -1.54 | -0.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.29 | -1.65 | 0.26 |
Zacks Consensus Estimate | -0.45 | -0.22 | -1.57 | -0.21 |
Earnings ESP | 0.00% | -31.82% | -5.10% | 225.80% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.48 | -0.40 | -0.40 | -0.40 | NA |
Estimate | -0.47 | -0.49 | -0.20 | -0.29 | NA |
Difference | -0.01 | 0.09 | -0.20 | -0.11 | -0.06 |
Surprise | -2.13% | 18.37% | -100.00% | -37.93% | -30.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more